Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia, Myelomonocytic, Acute 1Leukemia, Myeloid, Acute 1Leukemia, Monocytic, Acute 1Leukemia, Megakaryoblastic, Acute 1Leukemia, Erythroblastic, Acute 1Leukemia, Eosinophilic, Acute 1Leukemia, Basophilic, Acute 1Leukemia 1Congenital Abnormalities 1

Interventions

Cytarabine 54Etoposide 22Daunorubicin 20Filgrastim 18Busulfan 15Idarubicin 14Cyclophosphamide 14fludarabine phosphate 13Peripheral Blood Stem Cell Transplantation 12Mitoxantrone 12tipifarnib 11Gemtuzumab 10Flow Cytometry 10Antilymphocyte Serum 10Cyclosporine 9sargramostim 8Gene Expression Profiling 8Clofarabine 8Radiotherapy 7Methotrexate 7Topotecan 6valspodar 5aldesleukin 5Azacitidine 5alvocidib 4Observation 4Methylprednisolone 4Melphalan 4Granulocyte Colony-Stimulating Factor 4Arsenic Trioxide 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Leukemia, Megakaryoblastic, Acute × Proto-Oncogene Proteins c-kit × Clear all
NCT00509093 2020-03-17

Imatinib Mesylate in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia Who Have Received Chemotherapy

Case Comprehensive Cancer Center

Phase 2 Completed
32 enrolled 14 charts
Other hematologic neoplasm

Congenital Abnormalities, Leukemia, Erythroblastic, Acute, Leukemia, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Leukemia, Myeloid, Acute, Leukemia, Basophilic, Acute, Leukemia, Eosinophilic, Acute, Leukemia, Myelomonocytic, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡